ECI taps industry veteran Khalid Raja to drive strategic growth
Move comes amid rising regulatory pressures
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
Subscribe To Our Newsletter & Stay Updated